Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
GEN Biotechnology|October 6, 2025
Developing Treatments for Rare Diseases on a ShoestringAna C Puhl, Sarah Negri, Maggie A Z Hupcey, et al.Vaccine|September 18, 2007
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirusElizabeth A Reap, John Morris, Sergey A Dryga, et al.Vaccine|October 28, 2009
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteersDavid I Bernstein, Elizabeth A Reap, Kevin Katen, et al.The Journal of Clinical Investigation|August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancerMichael A Morse, Amy C Hobeika, Takuya Osada, et al.Vaccine|October 27, 2007
Development and preclinical evaluation of an alphavirus replicon vaccine for influenzaBolyn Hubby, Todd Talarico, Maureen Maughan, et al.Pageof 1